Literature DB >> 7190380

Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed.

E J Sachar, G Asnis, R S Nathan, U Halbreich, M A Tabrizi, F S Halpern.   

Abstract

Dextroamphetamine sulfate administered intravenously in the morning to 11 unmedicated depressed patients suppressed previously elevated plasma cortisol levels to normal in 90 minutes, a fall of 33% from baseline. Ten other depressed patients, without amphetamine, maintained high cortisol levels during the same time period. In each of five normal young men, amphetamine identically administered stimulated a rise in cortisol between 15 and 30 minutes after infusion, an acute response absent in ten of the 11 depressed patients; by 90 minutes after amphetamine administration, plasma cortisol had fallen to normal and identical levels in both groups. Since noradrenalin normally inhibits hypothalamic corticotropin releasing factor (and adrenocorticotropic hormone) secretion, a noradrenergic deficit may account for cortisol hypersecretion in depression; amphetamine may transiently "correct" this deficit in depressed patients, thereby reducing their cortisol secretion.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7190380     DOI: 10.1001/archpsyc.1980.01780200033003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  6 in total

1.  Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man.

Authors:  H L Fehm; R Holl; K Steiner; E Klein; K H Voigt
Journal:  Klin Wochenschr       Date:  1984-01-02

2.  d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.

Authors:  D P van Kammen; S C Schulz
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 3.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

4.  Circadian neuroendocrine functions in disorders of eating behavior.

Authors:  E Ferrari; F Magri; B Pontiggia; M Rondanelli; M Fioravanti; S B Solerte; S Severgnini
Journal:  Eat Weight Disord       Date:  1997-12       Impact factor: 4.652

5.  Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

Authors:  J I Nurnberger; S Simmons-Alling; L Kessler; S Jimerson; J Schreiber; E Hollander; C A Tamminga; N S Nadi; D S Goldstein; E S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Lack of correlation between DST results and urinary MHPG in depressed inpatients.

Authors:  H Lôo; M F Poirier; T Dennis; C Benkelfat; J M Vanelle; C Gay; A Galinowski; S Askienazy; B Scatton
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.